| ITALY | WP5 | |||
| Organization | University of Padova (UNIPD) | |||
| Name of cohort | PADOVA | |||
| Referring partner | UNIVR | |||
| Cohort Information | Country(-ies), cities, regions or centers involved | Padova, Italy | ||
| Time of data collection | 12/2020 | Ongoing | ||
| Enrolment | Inactive | |||
| Study setting | Single center | |||
| Population | Age | Adults | ||
| Type | Retrospective | |||
| Total number of patients | 6208 | |||
| Data collection | Clinical data | True | ||
| Serological data | True | |||
| Genetic data | False | |||
| Sample collection | True | |||
| Sample collected | Whole blood | Yes | ||
| PBMC | No | |||
| Dry-spot blood | No | |||
| Plasma | No | |||
| Serum | No | |||
| Stool | No | |||
| NP swabs | Yes | |||
| Other | Salivary swabs | |||
| Description | The cohort consists of over six thousand healthcare workers from the University Hospital of Padova, stratified by gender, age and job title. The subjects are vaccinated against SARS-CoV-2 and periodically tested with nasopharyngeal or salivary swabs. Subjects were also tested once with serology test between 1-3 months after the third dose of SARS-CoV-2 vaccine (approximately 1 year after the first dose). Clinical data were collected via online questionnaire. | |||